Literature DB >> 19878613

Measles transmission in immunized and partially immunized air travellers.

K P Coleman1, P G Markey.   

Abstract

Most cases of measles in Australia are associated with travel or acquired from travellers from overseas. This study presents a series of three secondary cases of measles acquired through contact with a case of infectious measles acquired in China. Two of the cases were fully immunized siblings sitting eight rows behind the index case on a 4(1/2)-h flight from Singapore. The third case was acquired in the airport where the index case was in transit. The report highlights the travel-associated risk of measles and discusses the heredity of vaccine-induced measles immunity.

Mesh:

Substances:

Year:  2009        PMID: 19878613     DOI: 10.1017/S0950268809991129

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

1.  Contact tracing of in-flight measles exposures: lessons from an outbreak investigation and case series, Australia, 2010.

Authors:  Frank Beard; Lucinda Franklin; Steven Donohue; Rodney Moran; Stephen Lambert; Marion Maloney; Jan Humphreys; Jessica Rotty; Nicolee Martin; Michael Lyon; Thomas Tran; Christine Selvey
Journal:  Western Pac Surveill Response J       Date:  2011-08-25

2.  Outbreak of measles among persons with secondary vaccine failure, China, 2018.

Authors:  Zhujiazi Zhang; Meng Chen; Rui Ma; Jingbin Pan; Luodan Suo; Li Lu
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

3.  Qualitative Variation among Commercial Immunoassays for Detection of Measles-Specific IgG.

Authors:  Donald R Latner; Sun B Sowers; Kiana Anthony; Heather Colley; Christine Badeau; Jessica Coates; Phili Wong; Yetunde Fakile; Cristina Interiano; Kevin B Pannell; Van Leung-Pineda; Manisha M Patel; Paul A Rota; Brandi M Limbago; Carole J Hickman
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

4.  Seroprevalence against the measles virus after vaccination or natural infection in an adult population in Madinah, Saudi Arabia.

Authors:  Waleed H Mahallawi; Nadir A Ibrahim
Journal:  Hum Vaccin Immunother       Date:  2021-02-11       Impact factor: 3.452

5.  Performance Evaluation of the VIDAS(®) Measles IgG Assay and Its Diagnostic Value for Measuring IgG Antibody Avidity in Measles Virus Infection.

Authors:  Julia Dina; Christian Creveuil; Stephanie Gouarin; Florent Viron; Amelie Hebert; Francois Freymuth; Astrid Vabret
Journal:  Viruses       Date:  2016-08-20       Impact factor: 5.048

6.  Notes from the field: measles transmission at a domestic terminal gate in an international airport - United States, January 2014.

Authors:  Jared S Vega; Miguel Escobedo; Cynthia R Schulte; Jennifer B Rosen; Stephanie Schauer; Rachel Wiseman; Susan A Lippold; Joanna J Regan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-12-19       Impact factor: 17.586

7.  Contact tracing following measles exposure on three international flights, Germany, 2017.

Authors:  Sebastian Thole; Daniela Kalhoefer; Maria An der Heiden; Doris Nordmann; Inka Daniels-Haardt; Annette Jurke
Journal:  Euro Surveill       Date:  2019-05

8.  Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections.

Authors:  Nicklas Sundell; Leif Dotevall; Martina Sansone; Maria Andersson; Magnus Lindh; Thomas Wahlberg; Tobias Tyrberg; Johan Westin; Jan-Åke Liljeqvist; Tomas Bergström; Marie Studahl; Lars-Magnus Andersson
Journal:  Euro Surveill       Date:  2019-04

Review 9.  Transmission routes of respiratory viruses among humans.

Authors:  Jasmin S Kutter; Monique I Spronken; Pieter L Fraaij; Ron Am Fouchier; Sander Herfst
Journal:  Curr Opin Virol       Date:  2018-01-17       Impact factor: 7.090

10.  Effect of vaccination on severity and infectiousness of measles during an outbreak in the Netherlands, 2013-2014.

Authors:  A S G van Dam; T Woudenberg; H E de Melker; J Wallinga; S J M Hahné
Journal:  Epidemiol Infect       Date:  2020-03-23       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.